AG Platkin, Division of Consumer Affairs Announce New Rules Aimed at Promoting Greater Transparency in Prescription Drug Pricing, Including How and Why Prices Are Increased

Advancing the Murphy Administration’s efforts to rein in the high cost of prescription drugs in New Jersey, Attorney General Matthew J. Platkin and the Division of Consumer Affairs (“Division”) announced specially adopted new rules promoting greater transparency in prescription drug pricing.

Attorney General Platkin, Multistate Coalition Announce $52 Million Settlement for Marriott, Starwood Data Breaches

Attorney General Matthew J. Platkin and the Division of Consumer Affairs announced that a coalition of 50 Attorneys General reached a $52 million settlement with Marriott International, Inc. to resolve investigations concerning two information security failures, including one widespread data breach.

Attorney General Platkin Announces Jersey City’s Participation in New Jersey’s ARRIVE Together Alternative Response Program

Attorney General Matthew J. Platkin announced that Jersey City will be Hudson County’s second municipality – in addition to the Hudson County Sheriff’s Office – to participate in the Alternative Responses to Reduce Instances of Violence and Escalation (ARRIVE) Together program.

Attorney General Platkin Leads Multistate Coalition to Defend Healthcare Access for Nation’s Dreamers

This Fall, DACA Recipients Can Enroll in ACA Exchanges for the First Time.

Attorney General Platkin Launches Statewide Campaign to Combat and Raise Public Awareness About Bias Incidents

Attorney General Matthew J. Platkin announced the launch of No Hate in the Garden State, a statewide campaign to raise public awareness about bias incidents and bias crimes, which target a protected status of the victim such as race, sex, gender, sexual orientation, or religion.

AG Platkin, Division on Civil Rights File Complaint in Superior Court Against Virtua Health for Alleged Discrimination Against Pregnant Patients

Hospital Mandates Universal Drug Testing of Pregnant Patients, Conducts Drug Tests Without Obtaining Informed Consent.

Translate »